Zangmeister Cancer Center is a clinical research site located in Columbus, Ohio, United States 43219.
Crixeo Health Trust Score: 82/100 (GOOD). This profile has not yet been claimed by the site owner.
Zangmeister Cancer Center has participated in 19 clinical trials with 12 currently active.
Therapeutic areas: SARS-CoV-2 Infection, Non Small Cell Lung Cancer, Advanced Solid Tumor.
Sponsors: MediMergent, LLC, OncoC4, Inc., Verastem, Inc..
Trust Score: 82/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Zangmeister Cancer Center has a Crixeo Trust Score of 82/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Zangmeister Cancer Center has 19 clinical trials on record, with 12 currently active. Their work covers SARS-CoV-2 Infection, Non Small Cell Lung Cancer, Advanced Solid Tumor.
Yes — Zangmeister Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.